BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 25973757)

  • 1. Suppression of autoimmunity by CD5(+) IL-10-producing B cells in lupus-prone mice.
    Baglaenko Y; Manion KP; Chang NH; Loh C; Lajoie G; Wither JE
    Genes Immun; 2015; 16(5):311-20. PubMed ID: 25973757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-10 Production Is Critical for Sustaining the Expansion of CD5+ B and NKT Cells and Restraining Autoantibody Production in Congenic Lupus-Prone Mice.
    Baglaenko Y; Manion KP; Chang NH; Gracey E; Loh C; Wither JE
    PLoS One; 2016; 11(3):e0150515. PubMed ID: 26964093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cd1d regulates B cell development but not B cell accumulation and IL10 production in mice with pathologic CD5(+) B cell expansion.
    Palmer VL; Nganga VK; Rothermund ME; Perry GA; Swanson PC
    BMC Immunol; 2015 Nov; 16():66. PubMed ID: 26537916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epistatic suppression of fatal autoimmunity in New Zealand black bicongenic mice.
    Loh C; Pau E; Lajoie G; Li TT; Baglaenko Y; Cheung YH; Chang NH; Wither JE
    J Immunol; 2011 May; 186(10):5845-53. PubMed ID: 21464090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue-specific expansion of NKT and CD5+B cells at the onset of autoimmune disease in (NZBxNZW)F1 mice.
    Morshed SR; Mannoor K; Halder RC; Kawamura H; Bannai M; Sekikawa H; Watanabe H; Abo T
    Eur J Immunol; 2002 Sep; 32(9):2551-61. PubMed ID: 12207339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-10 derived from CD1dhiCD5⁺ B cells regulates experimental autoimmune myasthenia gravis.
    Sheng JR; Quan S; Soliven B
    J Neuroimmunol; 2015 Dec; 289():130-8. PubMed ID: 26616882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences between CD8+ T cells in lupus-prone (NZB x NZW) F1 mice and healthy (BALB/c x NZW) F1 mice may influence autoimmunity in the lupus model.
    Karpouzas GA; La Cava A; Ebling FM; Singh RR; Hahn BH
    Eur J Immunol; 2004 Sep; 34(9):2489-99. PubMed ID: 15307181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo functional analysis of CD5+ and CD5- B cells of autoimmune NZB x NZW F1 mice.
    Ye YL; Chuang YH; Chiang BL
    Clin Exp Immunol; 1996 Nov; 106(2):253-8. PubMed ID: 8918570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential sensitivity to interleukins of CD5+ and CD5- anti-DNA antibody-producing B cells in murine lupus.
    Kanno K; Okada T; Abe M; Hirose S; Shirai T
    Autoimmunity; 1993; 14(3):205-14. PubMed ID: 7687154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adoptive transfer of autoimmune splenic dendritic cells to lupus-prone mice triggers a B lymphocyte humoral response.
    Sauma D; Crisóstomo N; Fuentes C; Gleisner MA; Hidalgo Y; Fuenzalida MJ; Rosemblatt M; Bono MR
    Immunol Res; 2017 Aug; 65(4):957-968. PubMed ID: 28741259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The paradox of CD5-expressing B cells in systemic lupus erythematosus.
    Youinou P; Renaudineau Y
    Autoimmun Rev; 2007 Dec; 7(2):149-54. PubMed ID: 18035326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B-cell linker protein expression contributes to controlling allergic and autoimmune diseases by mediating IL-10 production in regulatory B cells.
    Jin G; Hamaguchi Y; Matsushita T; Hasegawa M; Le Huu D; Ishiura N; Naka K; Hirao A; Takehara K; Fujimoto M
    J Allergy Clin Immunol; 2013 Jun; 131(6):1674-82. PubMed ID: 23534976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD5: a safeguard against autoimmunity and a shield for cancer cells.
    Dalloul A
    Autoimmun Rev; 2009 Feb; 8(4):349-53. PubMed ID: 19041428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Unknown Aspect of BAFF: Inducing IL-35 Production by a CD5
    Zhang Y; Li J; Zhou N; Zhang Y; Wu M; Xu J; Shen C; An X; Shen G; Yang M; Zhang C; Tao J
    J Invest Dermatol; 2017 Dec; 137(12):2532-2543. PubMed ID: 28844943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of Be1 and Be2 cells in systemic lupus erythematosus indicates elevated interleukin-10 producing CD5+ B cells.
    Amel Kashipaz MR; Huggins ML; Lanyon P; Robins A; Powell RJ; Todd I
    Lupus; 2003; 12(5):356-63. PubMed ID: 12765298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ly108 expression distinguishes subsets of invariant NKT cells that help autoantibody production and secrete IL-21 from those that secrete IL-17 in lupus prone NZB/W mice.
    Tang X; Zhang B; Jarrell JA; Price JV; Dai H; Utz PJ; Strober S
    J Autoimmun; 2014 May; 50():87-98. PubMed ID: 24508410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD5+ B cells in autoimmune disease and lymphoid malignancy.
    Shirai T; Hirose S; Okada T; Nishimura H
    Clin Immunol Immunopathol; 1991 May; 59(2):173-86. PubMed ID: 1706969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased interleukin 21 and follicular helper T-like cells and reduced interleukin 10+ B cells in patients with new-onset systemic lupus erythematosus.
    Wang L; Zhao P; Ma L; Shan Y; Jiang Z; Wang J; Jiang Y
    J Rheumatol; 2014 Sep; 41(9):1781-92. PubMed ID: 25028374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell cytokine imbalance towards production of IFN-gamma and IL-10 in NZB/W F1 lupus-prone mice is associated with autoantibody levels and nephritis.
    Enghard P; Langnickel D; Riemekasten G
    Scand J Rheumatol; 2006; 35(3):209-16. PubMed ID: 16766368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD5+ B cells from individuals with systemic lupus erythematosus express granzyme B.
    Hagn M; Ebel V; Sontheimer K; Schwesinger E; Lunov O; Beyer T; Fabricius D; Barth TF; Viardot A; Stilgenbauer S; Hepp J; Scharffetter-Kochanek K; Simmet T; Jahrsdörfer B
    Eur J Immunol; 2010 Jul; 40(7):2060-9. PubMed ID: 20394077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.